Skip to main content

Henry Schein, Inc. (HSIC) Stock Analysis

HoldVALUE-TRAP 1/5Moderate Confidence

Healthcare · Medical Distribution

Earnings in 5 days (2026-05-05). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Hold if already holding. Not a fresh buy at $74.06, but acceptable to hold if already in. Reasons: Thin upside margin: 6.1%; Earnings in 5 days (event risk).

Henry Schein distributes dental and medical products to over 1 million customers worldwide through Global Distribution/Value-Added Services (84.5% of 2025 revenue), Global Specialty Products (11.7%), and Global Technology (5.1%) segments. Operations span 34 countries with... Read more

$74.06+6.1% A.UpsideScore 4.9/10#4 of 5 Medical Distribution
Stop $70.32Target $78.49(analyst − 13%)A.R:R 1.2:1
Analyst target$90.21+21.8%14 analysts
$78.49our TP
$74.06price
$90.21mean
$64
$104

Hold if already holding. Not a fresh buy at $74.06, but acceptable to hold if already in. Reasons: Thin upside margin: 6.1%; Earnings in 5 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Multiple concerning factors. Consider reducing position. | News modifier +2 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Score 4.9/10, moderate confidence.

Passes 3/6 gates (clean insider activity, no SEC red flags, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and earnings proximity 5d<=7d. Suitability: moderate.

Thesis

Rewards
Strong earnings beat streak (3/4)
Positive news sentiment (+0.67)
Earnings estimates trending UP
Risks
Thin upside margin: 6.1%
Earnings in 5 days (event risk)
Weak overall score: 4.9/10

Key Metrics

P/E (TTM)22.6
P/E (Fwd)12.5
Mkt Cap$8.5B
EV/EBITDA13.0
Profit Mgn3.0%
ROE8.7%
Rev Growth7.7%
Beta0.88
DividendNone
Rating analysts22

Quality Signals

Piotroski F8/9

Options Flow

P/C0.33bullish
IV55%elevated
Max Pain$50-32.5% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Macd
0.0
Volume
0.0
Obv
1.0
Ma Position
4.0
Rsi
5.5
Volume distribution (falling OBV)Above 200-day MA
GatesMomentum 2.1<4.5A.R:R 1.2 < 1.5@spotEARNINGS PROXIMITY 5d<=7dInsider activity: OKNo SEC red flagsSEMI CYCLE PEAK CLEARSuitability: Moderate
RSI
43 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $71.31Resistance $81.10

Price Targets

$70
$78
A.Upside+6.0%
A.R:R1.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! NEWS_MOD=+2: SELL_IF_HOLDING → HOLD_IF_HOLDING
! Momentum score 2.1/10 — below 4.5 minimum
! Reward/Risk 1.2:1 at current price — below 1.5:1 minimum

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-05-05 (5d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is HSIC stock a buy right now?

Hold if already holding. Not a fresh buy at $74.06, but acceptable to hold if already in. Reasons: Thin upside margin: 6.1%; Earnings in 5 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Multiple concerning factors. Consider reducing position. | News modifier +2 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Target $78.49 (+6.0%), stop $70.32 (−5.3%), A.R:R 1.2:1. Score 4.9/10, moderate confidence.

What is the HSIC stock price target?

Take-profit target: $78.49 (+6.1% upside). Target $78.49 (+6.0%), stop $70.32 (−5.3%), A.R:R 1.2:1. Stop-loss: $70.32.

What are the risks of investing in HSIC?

Thin upside margin: 6.1%; Earnings in 5 days (event risk); Weak overall score: 4.9/10.

Is HSIC overvalued or undervalued?

Henry Schein, Inc. trades at a P/E of 22.6 (forward 12.5). TrendMatrix value score: 6.5/10. Verdict: Hold.

What do analysts say about HSIC?

22 analysts cover HSIC with a consensus score of 3.8/5. Average price target: $90.

What does Henry Schein, Inc. do?Henry Schein distributes dental and medical products to over 1 million customers worldwide through Global...

Henry Schein distributes dental and medical products to over 1 million customers worldwide through Global Distribution/Value-Added Services (84.5% of 2025 revenue), Global Specialty Products (11.7%), and Global Technology (5.1%) segments. Operations span 34 countries with 25,000+ employees.

Related stocks: CAH (Cardinal Health, Inc.) · COR (Cencora, Inc.) · AHG (Akso Health Group) · INCY (Incyte Corporation) · INDV (Indivior Pharmaceuticals, Inc.)